MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 56 filers reported holding MERSANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,788 | -61.4% | 61,250 | 0.0% | 0.03% | -61.2% |
| Q2 2023 | $201,513 | -96.7% | 61,250 | -86.4% | 0.07% | -96.0% |
| Q2 2021 | $6,111,000 | -16.1% | 450,000 | 0.0% | 1.68% | -1.8% |
| Q1 2021 | $7,281,000 | -54.4% | 450,000 | -25.0% | 1.71% | -51.9% |
| Q4 2020 | $15,966,000 | -18.3% | 600,000 | -42.9% | 3.56% | -37.0% |
| Q3 2020 | $19,551,000 | +33.7% | 1,050,000 | +68.0% | 5.65% | +46.4% |
| Q2 2020 | $14,625,000 | +25.4% | 625,000 | -68.8% | 3.86% | +24.8% |
| Q1 2020 | $11,660,000 | +154.4% | 2,000,000 | +150.0% | 3.09% | +254.3% |
| Q4 2019 | $4,584,000 | -57.2% | 800,000 | +33.3% | 0.87% | -72.3% |
| Q2 2018 | $10,716,000 | +144.2% | 600,000 | +115.6% | 3.15% | +255.2% |
| Q1 2018 | $4,388,000 | – | 278,244 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |